OpenURL Connection Search

Select item for more details and to access through your institution.

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments.
Published in:
2022
By:
- Jemaa, S.;
- Paulson, J. N.;
- Hutchings, M.;
- Kostakoglu, L.;
- Trotman, J.;
- Tracy, S.;
- de Crespigny, A.;
- Carano, R. A. D.;
- El-Galaly, T. C.;
- Nielsen, T. G.;
- Bengtsson, T.
Publication type:
journal article
[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
Published in:
2008
By:
- Kostakoglu L
Publication type:
Journal Article
Cerebral [<sup>18</sup> F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.
Published in:
Translational Psychiatry, 2016, v. 6, n. 9, p. e900, doi. 10.1038/tp.2016.175
By:
- Dickstein, D L;
- Pullman, M Y;
- Fernandez, C;
- Short, J A;
- Kostakoglu, L;
- Knesaurek, K;
- Soleimani, L;
- Jordan, B D;
- Gordon, W A;
- Dams-O'Connor, K;
- Delman, B N;
- Wong, E;
- Tang, C Y;
- DeKosky, S T;
- Stone, J R;
- Cantu, R C;
- Sano, M;
- Hof, P R;
- Gandy, S
Publication type:
Article
An automated quantification algorithm for evaluating total metabolic tumor volume in patients with FDG‐avid lymphomas using a deep learning model.
Published in:
Hematological Oncology, 2023, v. 41, p. 342, doi. 10.1002/hon.3164_245
By:
- Xu, T.;
- Jemaa, S.;
- Kumar, M.;
- Balasubramanian, S.;
- Shamas‐Din, A.;
- Lyalina, S.;
- Ounadjela, S.;
- Malik, B.;
- Lee, J.;
- Morales, S. Figueroa;
- Nielsen, T.;
- Carano, R. A. D.;
- Kostakoglu, L.;
- Capra, W.
Publication type:
Article
CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.72_2879
By:
- LaCasce, A. S.;
- Dockter, T.;
- Ruppert, A.;
- Kostakoglu, L.;
- Schöder, H.;
- Hsi, E. D.;
- Bogart, J. A.;
- Cheson, B. D.;
- Wagner‐Johnston, N. D.;
- Abramson, J. S.;
- Maddocks, K. J.;
- Leonard, J. P.;
- Bartlett, N. L.
Publication type:
Article
PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 250, doi. 10.1002/hon.59_2630
By:
- Berry, D.A.;
- Broglio, K.R.;
- Ward, C.;
- Sahin, D.;
- Nielsen, T.;
- Mattiello, F.;
- McGlothlin, A.E.;
- Wendelberger, B.A.;
- Foster, M.;
- Nowakowski, G.S.;
- Kostakoglu, L.
Publication type:
Article
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP.
Published in:
Hematological Oncology, 2019, v. 37, p. 37, doi. 10.1002/hon.6_2629
By:
- Nowakowski, G.S.;
- Hong, F.;
- Scott, D.W.;
- Macon, R.;
- King, R.L.;
- Habermann, T.M.;
- Wagner‐Johnston, N.;
- Casulo, C.;
- Wade, J.L.;
- Nagargoje, G.G.;
- Reynolds, C.M.;
- Cohen, J.B.;
- Khan, N.;
- Amengual, J.;
- Richards, K.L.;
- Little, R.F.;
- Leonard, J.P.;
- Friedberg, J.W.;
- Kostakoglu, L.;
- Kahl, B.S.
Publication type:
Article
RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 52, doi. 10.1002/hon.21_2629
By:
- Chauvie, S.;
- Dalmasso, F.;
- Pierce, L.;
- Vitolo, U.;
- Martelli, M.;
- Sehn, L.H.;
- Trněný, M.;
- Nielsen, T.;
- Sahin, D.;
- Lee, C.;
- Mattiello, F.;
- Berchialla, P.;
- Kinahan, P.E.;
- Kostakoglu, L.
Publication type:
Article
BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 50, doi. 10.1002/hon.20_2629
By:
- Trněný, M.;
- Canales Ruiz, I.;
- Martelli, M.;
- Sehn, L.H.;
- Vitolo, U.;
- Brown, H.;
- Nielsen, T.;
- Sellam, G.;
- Kostakoglu, L.
Publication type:
Article
ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP.
Published in:
Hematological Oncology, 2019, v. 37, p. 37, doi. 10.1002/hon.6_2629
By:
- Nowakowski, G.S.;
- Hong, F.;
- Scott, D.W.;
- Macon, R.;
- King, R.L.;
- Habermann, T.M.;
- Wagner‐Johnston, N.;
- Casulo, C.;
- Wade, J.L.;
- Nagargoje, G.G.;
- Reynolds, C.M.;
- Cohen, J.B.;
- Khan, N.;
- Amengual, J.;
- Richards, K.L.;
- Little, R.F.;
- Leonard, J.P.;
- Friedberg, J.W.;
- Kostakoglu, L.;
- Kahl, B.S.
Publication type:
Article
PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 250, doi. 10.1002/hon.59_2630
By:
- Berry, D.A.;
- Broglio, K.R.;
- Ward, C.;
- Sahin, D.;
- Nielsen, T.;
- Mattiello, F.;
- McGlothlin, A.E.;
- Wendelberger, B.A.;
- Foster, M.;
- Nowakowski, G.S.;
- Kostakoglu, L.
Publication type:
Article
RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 52, doi. 10.1002/hon.21_2629
By:
- Chauvie, S.;
- Dalmasso, F.;
- Pierce, L.;
- Vitolo, U.;
- Martelli, M.;
- Sehn, L.H.;
- Trněný, M.;
- Nielsen, T.;
- Sahin, D.;
- Lee, C.;
- Mattiello, F.;
- Berchialla, P.;
- Kinahan, P.E.;
- Kostakoglu, L.
Publication type:
Article
BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 50, doi. 10.1002/hon.20_2629
By:
- Trněný, M.;
- Canales Ruiz, I.;
- Martelli, M.;
- Sehn, L.H.;
- Vitolo, U.;
- Brown, H.;
- Nielsen, T.;
- Sellam, G.;
- Kostakoglu, L.
Publication type:
Article
END OF TREATMENT PET-CT PREDICTS PROGRESSION-FREE SURVIVAL IN DLBCL AFTER FIRST-LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 184, doi. 10.1002/hon.2438_45
By:
- Kostakoglu, L.;
- Martelli, M.;
- Belada, D.;
- Carella, A.M.;
- Chua, N.;
- Gonzalez ‐ Barca, E.;
- Hong, X.;
- Pinto, A.;
- Sehn, L.H.;
- Shi, Y.;
- Tatsumi, Y.;
- Fingerle ‐ Rowson, G.;
- Mattiello, F.;
- Nielsen, T.;
- Sahin, D.;
- Vitolo, U.;
- Trněný, M.
Publication type:
Article
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Published in:
2009
By:
- Kao J;
- Vu HL;
- Genden EM;
- Mocherla B;
- Park EE;
- Packer S;
- Som PM;
- Kostakoglu L;
- Kao, Johnny;
- Vu, Ha Linh;
- Genden, Eric M;
- Mocherla, Bharat;
- Park, Eunice E;
- Packer, Stuart;
- Som, Peter M;
- Kostakoglu, Lale
Publication type:
journal article
Impact of radiotherapy on normal brain tissue: semi-automated quantification of decrease in perfusion.
Published in:
2000
By:
- Gülaldi, Nedim;
- Kostakoĝlu, Lale;
- Uzal, Dilek;
- Hayran, Mutlu;
- Elahi, Nazenin;
- Uysal, Uĝur;
- Aktaş, Ayşe;
- Atahan, Lale;
- Bekdik, Coşkun;
- Gülaldi, N C;
- Kostakoğlu, L;
- Uzal, D;
- Hayran, M;
- Elahi, N;
- Uysal, U;
- Aktaş, A;
- Atahan, L;
- Bekdik, C
Publication type:
journal article
Phase I Radioimmunotherapy Trial with Iodine-131-CC49 in Metastatic Colon Carcinoma.
Published in:
Journal of Nuclear Medicine, 1995, v. 36, n. 4, p. 586
By:
- Divgi, C. R.;
- Scott, A. M.;
- Dantis, L.;
- Capiteffi, P.;
- Siler, K.;
- Hilton, S.;
- Finn, R. D.;
- Kemeny, N.;
- Kelsen, D.;
- Kostakoglu, L.;
- Schiom, J.;
- Larson, S. M.
Publication type:
Article

Found: 17